Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Template:BioblastAlert2023"

From Bioblast
m
Line 7: Line 7:
|'''"Obesity has an opposing association with mitochondrial respiration in adipose- and liver tissue with no overall association with NAFLD (nonalcoholic fatty liver disease) severity."'''  <br>
|'''"Obesity has an opposing association with mitochondrial respiration in adipose- and liver tissue with no overall association with NAFLD (nonalcoholic fatty liver disease) severity."'''  <br>
* Pedersen JS, Rygg MO, Chrøis K, Sustarsic EG, Gerhart-Hines Z, Wever Albrechtsen NJ, Serizawa RR, Kristiansen VB, Basse AL, Boilesen AEB, Olsen BH, Hansen T, Gluud LL, Madsbad S, Larsen S, Bendtsen F, Dela F (2022) Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration. [[Pedersen 2022 Nat Commun|»Bioblast link«]]
* Pedersen JS, Rygg MO, Chrøis K, Sustarsic EG, Gerhart-Hines Z, Wever Albrechtsen NJ, Serizawa RR, Kristiansen VB, Basse AL, Boilesen AEB, Olsen BH, Hansen T, Gluud LL, Madsbad S, Larsen S, Bendtsen F, Dela F (2022) Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration. [[Pedersen 2022 Nat Commun|»Bioblast link«]]
from the O2k-Network »[[DK Copenhagen Gerhart-Hines Z]]« and »[[DK Copenhagen Larsen S]]«
:from the O2k-Network »[[DK Copenhagen Gerhart-Hines Z]]« and »[[DK Copenhagen Larsen S]]«
|}
|}


Line 14: Line 14:
|'''"BAM15 is a tolerable and efficacious protonophore that protects against diet‐induced obesity."'''  <br>
|'''"BAM15 is a tolerable and efficacious protonophore that protects against diet‐induced obesity."'''  <br>
* Axelrod CL, King WT, Davuluri G, Noland RC, Hall J, Hull M, Dantas WS, Zunica ER, Alexopoulos SJ, Hoehn KL, Langohr I, Stadler K, Doyle H, Schmidt E, Nieuwoudt S, Fitzgerald K, Pergola K, Fujioka H, Mey JT, Fealy C, Mulya A, Beyl R, Hoppel CL, Kirwan JP (2021) BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control. [[Axelrod 2021 EMBO Mol Med|»Bioblast link«]]
* Axelrod CL, King WT, Davuluri G, Noland RC, Hall J, Hull M, Dantas WS, Zunica ER, Alexopoulos SJ, Hoehn KL, Langohr I, Stadler K, Doyle H, Schmidt E, Nieuwoudt S, Fitzgerald K, Pergola K, Fujioka H, Mey JT, Fealy C, Mulya A, Beyl R, Hoppel CL, Kirwan JP (2021) BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control. [[Axelrod 2021 EMBO Mol Med|»Bioblast link«]]
from the O2k-Network »[[US LA Baton Rouge Noland RC]]« and »[[US OH Cleveland Hoppel CL]]«
:from the O2k-Network »[[US LA Baton Rouge Noland RC]]« and »[[US OH Cleveland Hoppel CL]]«
|}
|}



Revision as of 13:39, 2 June 2023


Bioblast alert 2023(03) - mitObestiy and healthy aging: 2023-06-01

O2k-Publications in the MiPMap "Obesity has an opposing association with mitochondrial respiration in adipose- and liver tissue with no overall association with NAFLD (nonalcoholic fatty liver disease) severity."
  • Pedersen JS, Rygg MO, Chrøis K, Sustarsic EG, Gerhart-Hines Z, Wever Albrechtsen NJ, Serizawa RR, Kristiansen VB, Basse AL, Boilesen AEB, Olsen BH, Hansen T, Gluud LL, Madsbad S, Larsen S, Bendtsen F, Dela F (2022) Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration. »Bioblast link«
from the O2k-Network »DK Copenhagen Gerhart-Hines Z« and »DK Copenhagen Larsen S«
O2k-Publications in the MiPMap "BAM15 is a tolerable and efficacious protonophore that protects against diet‐induced obesity."
  • Axelrod CL, King WT, Davuluri G, Noland RC, Hall J, Hull M, Dantas WS, Zunica ER, Alexopoulos SJ, Hoehn KL, Langohr I, Stadler K, Doyle H, Schmidt E, Nieuwoudt S, Fitzgerald K, Pergola K, Fujioka H, Mey JT, Fealy C, Mulya A, Beyl R, Hoppel CL, Kirwan JP (2021) BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control. »Bioblast link«
from the O2k-Network »US LA Baton Rouge Noland RC« and »US OH Cleveland Hoppel CL«
MitoPedia
Decline of mitochondrial fitness in overweight states is a biomarker of the systemic mitObesity syndrome, providing a mechanistic link between common obesity and associated chronic comorbidities.

Body mass excess provides an evidence-based index of underweight, overweight and obesity across all heights and ages, applicable to all populations for which the healthy reference baseline is established.
- »Body mass excess and mitObesity«

MiP2023 Obergurgl AT

Join the 15th MiPconference: Bioenergetics Communications on ‘mitObesity and Healthy Aging’
Date: 2023 July 27-30
Location: Obergurgl, AT
More information: MiP2023 Obergurgl AT
Registration: online form


Bioblast alert 2023(02) - DORA and BEC: 2023-05-10

DORA
The San Francisco Declaration on Research Assessment (DORA) turns 10 years on May 16, 2023.

»Sign the declaration«

Bombaca 2022 BEC
Implementing DORA principles by publishing in Bioenergetics Communications - beyond counting papers: a presentation by Erich Gnaiger, BEC Editor-in-chief.
  • Date: 2023 May 16, Tuesday
  • Time: 16:00 (GMT+1)
  • Join via Livestream
Location: MiPArt, Schoepfstrasse 18, 6020 Innsbruck, AT
Beyond counting papers "The burden of responsibilities for an urgent change of the academic publishing ecosystem and scientific communication culture must be shared between the shoulders of individual scientists, the backbone of scientific institutions, and the neurology of governmental regulations and funding agencies."
MiP2023 Obergurgl AT Interested in publishing on ‘mitObesity and Healthy Aging’ in BEC?

Join the 15th MiPconference, 2023 July 27-30, Obergurgl, AT: MiP2023_Obergurgl_AT
We invite original articles to be published in a special issue of Bioenergetics Communications.


Bioblast alert 2023(01) - Trypanosomatids: 2023-01-18

Alencar 2022 BEC
Bionenerg Commun 2022.17: a review and hypothesis to explain the unusual metabolic network and its biological significance for bloodstream Trypanosoma brucei forms.
  • Alencar MB, Ramos EV, Silber AM, Zíková A, Oliveira MF (2022) The extraordinary energy metabolism of the bloodstream Trypanosoma brucei forms: a critical review and hypothesis. Bioenerg Commun 2022.17. https://doi.org/10.26124/bec:2022-0017
Bombaca 2022 BEC
Bionenerg Commun 2022.20: a discussion of 17 years of data on trypanosomatids' mitochondrial susceptibility and adaptative processes.
O2k-Publications in the MiPMap "We not only identified a new source of ROS production in Leishmania, but also described, for the first time, an enzyme with both ferric iron reductase and Nox activities."
  • Rocco-Machado N, Cosentino-Gomes D, Nascimento MT, Paes-Vieira L, Khan YA, Mittra B, Andrews NW, Meyer-Fernandes JR (2019) Leishmania amazonensis ferric iron reductase (LFR1) is a bifunctional enzyme: Unveiling a NADPH oxidase activity. »Bioblast link«